Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk (Q38261196)

1 September 2017

1 reference

title

Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk (English)

1 reference

1 September 2017

3

Jean-Pierre Després

1 reference

1 September 2017

Patrick Mathieu

1

1 reference

PubMed ID

25326657

1 September 2017

Marie-Chloé Boulanger

series ordinal

2

1 reference

1 September 2017

1 December 2014

1 reference

Reviews in Endocrine and Metabolic Disorders

1 September 2017

1 reference

1 September 2017

15

1 reference

1 September 2017

4

1 reference

1 September 2017

289-298

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-014-9299-3

1 September 2017

0 references

cites work

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Visceral obesity and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Metabolic syndrome: a multiplex cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Abdominal and femoral adipose tissue lipolysis and cardiovascular disease risk factors in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Obesity, inflammation, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Leptin enhances the calcification of vascular cells: artery wall as a target of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Lipotoxicity, overnutrition and energy metabolism in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Ceramides in insulin resistance and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Basic mechanisms of calcific aortic valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Inflammation in atherosclerosis: from pathophysiology to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Postprandial variations of plasma inflammatory markers in abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Phosphorylation and activation of hormone-sensitive adipocyte phosphodiesterase type 3B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Signalling mechanisms regulating lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

T-cadherin is critical for adiponectin-mediated cardioprotection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Inflammasomes and their roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

IKKβ links vascular inflammation to obesity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The major inflammatory mediator interleukin-6 and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The small, dense LDL phenotype as a correlate of postprandial lipemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

High-density lipoprotein regulates calcification of vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

An abundant dysfunctional apolipoprotein A1 in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Future of cholesteryl ester transfer protein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

The triglyceride/high-density lipoprotein cholesterol ratio, the small dense low-density lipoprotein phenotype, and ischemic heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Thiazolidinediones enhance sodium-coupled bicarbonate absorption from renal proximal tubules via PPARγ-dependent nongenomic signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

Effective tobacco control is key to rapid progress in reduction of non-communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9299-3

An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls

21 January 2018

1 reference

12 December 2020

Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice

1 reference

12 December 2020

Inflammation and cardiovascular disease: is abdominal obesity the missing link?

1 reference

12 December 2020

1 reference

12 December 2020

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study

1 reference

12 December 2020

Effect of leptin on vascular calcification in apolipoprotein E-deficient mice

1 reference

12 December 2020

Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid

1 reference

12 December 2020

Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity

1 reference

12 December 2020

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

1 reference

12 December 2020

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease

1 reference

12 December 2020

Hypoadiponectinemia is associated with valvular inflammation and faster disease progression in patients with aortic stenosis

1 reference

12 December 2020

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice

1 reference

12 December 2020

Low plasma adiponectin levels predict progression of coronary artery calcification

1 reference

12 December 2020

10.1007/S11154-014-9299-3

Identifiers

DOI

1 reference

PubMed ID

25326657

Dimensions Publication ID

1 September 2017

0 references

1 reference

PubMed ID

25326657